Xencor director Ranieri sells 81,252 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xencor director Richard J. Ranieri exercised stock options covering 75,755 shares on November 10, 2026, at exercise prices of $9.43, $21.31, $23.04 and $26.58 per share, acquiring the corresponding common shares. He also sold 81,252 shares: 70,080 at a weighted-average $39.20 per share and 11,172 at a weighted-average $39.59. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F3 | 15,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F4 | 21,412 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5 | 11,971 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F6 | 27,372 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $23.04 | $346K |
| Exercise | Common Stock | 21,412 | $26.58 | $569K |
| Exercise | Common Stock | 11,971 | $21.31 | $255K |
| Exercise | Common Stock | 27,372 | $9.43 | $258K |
| Sale | Common Stock F1 | 70,080 | $39.20 | $2.75M |
| Sale | Common Stock F2 | 11,172 | $39.59 | $442K |
Footnotes (6)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.51 to $39.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. 25% of the shares subject to the option vested on the one year anniversary of December 18, 2017 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
- F4. 25% of the shares subject to the option vested on the one year anniversary of June 23, 2022 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
- F5. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 13, 2024, such that the total number of shares was fully vested on June 13, 2025.
- F6. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares was fully vested on June 12, 2026.
Key Figures
Key Terms
weighted average price financial
Vesting Commencement Date technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did XNCR director Richard J. Ranieri exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.